TP53 and esophageal squamous cell carcinoma: Liu et al., found that loss or mutation of p53 drives lncRNA AGPG, which interacts with and stabilizes PFKFB3, thereby activating glycolytic flux and promoting cell cycle progression in ESCC (Fig. 3D) [43].